Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 43 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/01/20
End: 03/31/22
Due: 03/31/23
Phase: N/A
Priority: Normal
Start: 05/27/21
End: 02/02/22
Due: 02/02/23
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 03/31/21
Due: 03/31/22
Phase: N/A
Priority: Normal
Start: 11/01/20
End: 09/01/21
Due: 09/01/22
Phase: N/A
Priority: Normal
Start: 11/26/19
End: 12/26/21
Due: 12/26/22
Phase: N/A
Priority: Normal
Start: 01/07/18
End: 12/01/23
Due: 12/01/24
Phase: N/A
Priority: Normal
Start: 08/01/23
End: 06/01/27
Due: 06/01/28
Phase: N/A
Priority: Normal
Start: 09/11/19
End: 11/20/20
Due: 11/20/21
Phase: N/A
Priority: Normal
Start: 01/01/18
End: 04/01/21
Due: 04/01/22
Phase: N/A
Priority: Normal
Start: 02/01/23
End: 01/31/25
Due: 01/31/26
Phase: N/A
Priority: Normal
Start: 02/11/21
End: 04/08/22
Due: 04/08/23
Phase: N/A
Priority: Normal
Start: 02/25/21
End: 07/11/22
Due: 07/11/23
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 12/01/20
End: 03/01/21
Due: 03/01/22
Phase: N/A
Priority: Normal
Start: 07/01/23
End: 12/30/24
Due: 12/30/25
Phase: N/A
Priority: Normal
Start: 05/17/17
End: 10/27/17
Due: 10/27/18
Phase: N/A
Priority: Normal
Start: 07/31/23
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 06/10/23
End: 10/31/23
Due: 10/31/24
Phase: N/A
Priority: Normal
Start: 02/03/21
End: 05/10/22
Due: 05/10/23
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 01/31/16
Due: 01/31/17
Breathomics: May it Become an Affordable, New Tool for Early Diagnosis and Screening of Lung Cancer?
Phase: N/A
Priority: Normal
Start: 04/01/21
End: 08/01/23
Due: 08/01/24
Phase: N/A
Priority: Normal
Start: 03/01/20
End: 03/15/21
Due: 03/15/22
Phase: N/A
Priority: Normal
Start: 05/24/17
End: 10/17/17
Due: 10/17/18
Phase: N/A
Priority: Normal
Start: 03/31/03
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 01/30/19
End: 01/30/22
Due: 01/30/23